{"id":"W4286515998","doi":"10.1016/s0140-6736(22)01199-0","title":"Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Lundbeckfonden; Pfizer","keywords":"Dupilumab; Atopic dermatitis; Medicine; Double blind; Dermatology; Randomized controlled trial; Internal medicine; Alternative medicine; Placebo; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001679797,0.0001196997,0.0005421367,0.000059308,0.0001248386,0.000008743752,0.0001340694,0.0000358514,0.0001688404],"category_scores_gemma":[0.00009251664,0.00008188689,0.00004201826,0.0001643613,0.00007741202,0.00004102282,0.00006774029,0.0002223929,0.000005201421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000278546,"about_ca_system_score_gemma":0.00008921041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000033434,"about_ca_topic_score_gemma":0.00005602395,"domain_scores_codex":[0.9989694,0.0001623764,0.0002733652,0.000179766,0.0001953068,0.0002197726],"domain_scores_gemma":[0.9991775,0.000324018,0.00009001435,0.0002942237,0.00003093908,0.0000833537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9922111,0.0005391683,0.001259228,0.000136473,0.0001186705,0.000123942,0.002188981,0.0002525789,0.000003823634,0.00009859087,0.002232982,0.0008344773],"study_design_scores_gemma":[0.9920501,0.0005697776,0.004466032,0.0001665942,0.0001437644,0.00008237085,0.0007686148,0.0004268737,0.00006497309,0.00002741437,0.001131681,0.0001018001],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926814,0.0005438422,0.00001039811,0.002421752,0.0001162076,0.002257781,0.00006804162,0.00002842648,0.001872179],"genre_scores_gemma":[0.9986917,0.00008128584,0.00007450253,0.0006610188,0.0001184303,0.0002371851,0.00006390264,0.00001129923,0.00006063264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00601037,"threshold_uncertainty_score":0.3339251,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03158100381799388,"score_gpt":0.3123571558196823,"score_spread":0.2807761520016884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}